Fernandes Peter

CIK 00016426181 companyHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001642618

Recent Transactions

19 trades

Award
Bellerophon Therapeutics, Inc.
Stock Options (Right to Buy)
2023-06-07−100,000→ 100,000 total
Award
Bellerophon Therapeutics, Inc.
Stock Options (right to buy)
2023-02-10$1.52/sh+100,000→ 100,000 total
Tax Payment
Bellerophon Therapeutics, Inc.
Common Stock
2022-12-09$0.93/sh−9,985→ 22,515 total
Exercise/Conversion
Bellerophon Therapeutics, Inc.
Common Stock
2022-12-09+32,500→ 32,500 total
Exercise/Conversion
Bellerophon Therapeutics, Inc.
Restricted Stock Units
2022-12-09−32,500→ 32,500 total
Award
Bellerophon Therapeutics, Inc.
Restricted Stock Units
2022-01-26+65,000→ 65,000 total
Tax Payment
Bellerophon Therapeutics, Inc.
Common Stock
2019-11-15$0.34/sh−40,280→ 182,022 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2019-09-26+175,500→ 470,290 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2019-01-02+12,500→ 294,790 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2018-11-20+137,500→ 282,290 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2018-09-25+119,626→ 222,302 total
Tax Payment
Bellerophon Therapeutics, Inc.
Common Stock
2018-06-12$2.37/sh−11,304→ 102,676 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2018-01-12+31,527→ 113,980 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2018-01-12+100,000→ 100,000 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2017-03-16+82,052→ 117,774 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2016-12-07+30,000→ 30,000 total
Tax Payment
Bellerophon Therapeutics, Inc.
Common Stock
2016-09-12$1.38/sh−19,785→ 35,722 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2016-01-19+53,112→ 55,507 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2015-05-18+10,000→ 10,000 total

Companies

Bellerophon Therapeutics, Inc.
Chief Regulatory Officer

Recent Filings

Address

C/O BELLEROPHON THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 301

HAMPTON, NJ, 08827

View on SEC.gov